Laser-assisted IVC filter removal device earns FDA’s breakthrough device designation

Royal Philips has received the FDA’s breakthrough device designation for its new laser-assisted inferior vena cava (IVC) filter removal solution.

The device is intended to help implanting physicians remove IVC filters as long as they are no longer needed. These filters are associated with certain long-term risks if not properly removed in time, Philips emphasized in its announcement.

The FDA’s decision was based in part on two independent clinical studies. Both were published in the Journal of the American Heart Associationone in August 2020, the other in November 2020.

"There is a clear need for an innovative device to help physicians more safely perform advanced IVC filter removal and I believe that the Philips excimer laser sheath may greatly enhance the options available to succeed in filter retrieval,” interventional radiologist Atul Gupta, MD, chief medical officer of image-guided therapy for Philips, said in a statement. “Breakthrough device designation is an important step for a medical innovation such as this one to help fill an unmet need in patient care.”

“Laser-assisted filter retrieval may be a critical tool for the safe retrieval of filters with extended implantation times,” added Kush R Desai, MD, an associate professor at Northwestern University Feinberg School of Medicine in Chicago and a researcher with experience using the device. “Breakthrough Device Designation reflects the potential impact that this technology could have on countless patients where this technology can be applied to safely retrieve filters by an expert physician, thereby reducing their risk of significant filter-related complications.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup